MiR-6924-5p-rich exosomes derived from genetically modified Scleraxis-overexpressing PDGFRα(+) BMMSCs as novel nanotherapeutics for treating osteolysis during tendon-bone healing and improving healing strength

已完结 10 由 er1 发布于 2024/4/2 15:48:29

DOI:10.1016/j.biomaterials.2021.121242
作者：Wang Feng , Qian Jin , Yang Ming-yu , He Yang , Tao Xu , Shi You-xing , Bian Xu-ting , Chen Wan , Wang Yun-jiao , Wang Huan , Yang Ai-ning , Li Yan , Tang Hong , Huang Pan , Mu Mi-duo , He Gang , Zhou Mei , Kang Xia , Tang Kang-lai
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Osteolysis at the tendon-bone interface can impair pullout strength during tendon-bone healing and lead to surgery failure, but the effects of clinical treatments are not satisfactory. Mesen

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)Dibasic Ester: A Low Risk, Green Organic Solvent Alternative